Evidence map›Paper›PMID 21978368›Full record

ArticleACS chemical biology2011

Immune interference in Mycobacterium tuberculosis intracellular iron acquisition through siderocalin recognition of carboxymycobactins.

Trisha M Hoette, Matthew C Clifton, Anna M Zawadzka, Meg A Holmes, Roland K Strong, Kenneth N Raymond

Abstract readLetter
In one paragraph

Article in ACS chemical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Coordination Chemistry of Microbial Iron Transport.Accounts of chemical research · 2015
    Article
  10. Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  11. Review
  12. Article
  13. Host-directed therapeutics for tuberculosis: can we harness the host?Microbiology and molecular biology reviews : MMBR · 2013
    Review
  14. Article
  15. Article
  16. Review
  17. Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition.Interdisciplinary perspectives on infectious diseases · 2012
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Trisha M Hoette
Matthew C Clifton
Anna M Zawadzka
Meg A Holmes
Roland K Strong
Kenneth N Raymond

Funding

Coordination Chemistry of Microbial Iron Transport CompoundsR01AI011744 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAYMOND, KENNETH N · 1986 to 2013
$4.1M
Microbial siderophore-specific innate immune responsesR01AI059432 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STRONG, ROLAND K · 2005 to 2008
$1.1M
NIAID NIH HHS R01 AI011744NIAID NIH HHS R01 AI059432NIAID NIH HHS R01AI11744NIAID NIH HHS R01AI59432
6 · The paper itself

Abstract

The innate immune system antibacterial protein Siderocalin (Scn) binds ferric carboxymycobactin (CMB) and also several catecholate siderophores. Although the recognition of catecholates by Scn has been thoroughly investigated, the binding interactions of Scn with the full spectrum of CMB isoforms have not been studied. Here we show that Scn uses different binding modes for the limited subset of bound CMB isoforms, resulting in a range of binding affinities that are much weaker than other siderophore targets of Scn. Understanding the binding interaction between Scn and CMBs provides clues for the influence of Scn on mycobacterial iron acquisition.

Indexed as

Acute-Phase ProteinsCarrier ProteinsHumansImmunity, InnateIronIron Chelating AgentsLipocalin-2LipocalinsModels, MolecularMolecular ConformationMycobacterium tuberculosisOxazolesProto-Oncogene ProteinsStatic ElectricityAcute-Phase ProteinsCarrier ProteinsIronIron Chelating AgentsLCN2 protein, humanLipocalin-2LipocalinsmycobactinsOxazolesProto-Oncogene Proteins

Identifiers

PMID21978368
PMCPMC3241878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.